These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21855538)

  • 1. Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation.
    Kirovski G; Dorn C; Huber H; Moleda L; Niessen C; Wobser H; Schacherer D; Buechler C; Wiest R; Hellerbrand C
    Exp Mol Pathol; 2011 Dec; 91(3):780-3. PubMed ID: 21855538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.
    Haukeland JW; Damås JK; Konopski Z; Løberg EM; Haaland T; Goverud I; Torjesen PA; Birkeland K; Bjøro K; Aukrust P
    J Hepatol; 2006 Jun; 44(6):1167-74. PubMed ID: 16618517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
    Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.
    Rull A; Rodríguez F; Aragonès G; Marsillach J; Beltrán R; Alonso-Villaverde C; Camps J; Joven J
    Cytokine; 2009 Dec; 48(3):273-9. PubMed ID: 19748796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model for nonalcoholic steatohepatitis.
    Sundaresan S; Vijayagopal P; Mills N; Imrhan V; Prasad C
    J Nutr Biochem; 2011 Oct; 22(10):979-84. PubMed ID: 21190824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation.
    Kirovski G; Gäbele E; Dorn C; Moleda L; Niessen C; Weiss TS; Wobser H; Schacherer D; Buechler C; Wasmuth HE; Hellerbrand C
    Int J Clin Exp Pathol; 2010 Aug; 3(7):675-80. PubMed ID: 20830238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
    Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
    Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN; Tao RY; Tian JY; Liu GT; Ye F
    Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity.
    Chen A; Mumick S; Zhang C; Lamb J; Dai H; Weingarth D; Mudgett J; Chen H; MacNeil DJ; Reitman ML; Qian S
    Obes Res; 2005 Aug; 13(8):1311-20. PubMed ID: 16129712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice.
    Inafuku M; Nagao K; Nomura S; Shirouchi B; Inoue N; Nagamori N; Nakayama H; Toda T; Yanagita T
    Br J Nutr; 2012 Mar; 107(5):639-46. PubMed ID: 21787451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.
    Aigner E; Strasser M; Haufe H; Sonnweber T; Hohla F; Stadlmayr A; Solioz M; Tilg H; Patsch W; Weiss G; Stickel F; Datz C
    Am J Gastroenterol; 2010 Sep; 105(9):1978-85. PubMed ID: 20407430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice.
    Yu R; Kim CS; Kwon BS; Kawada T
    Obesity (Silver Spring); 2006 Aug; 14(8):1353-62. PubMed ID: 16988077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
    Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R
    Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.